Poseida Therapeutics, Inc. (PSTX) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Financial Fact:
Net (loss) income: -384.56K
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Net (loss) income: -384.56K
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported Q4 EPS of ($0.27), $0.12 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $24.99 million versus the consensus estimate of $6.65 million.
For earnings history and earnings-related data on Poseida Therapeutics, Inc. (PSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
